You are being directed to ZacksTrade, a division of Zacks & Company and licensed broker-dealer. ZacksTrade and are separate but affiliated companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.

If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.

OK Cancel

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

Zacks #1 Stocks on the Move 11/26/2014

Company Name Symbol %Change
Questcor Pharmaceuticals has Relatively Underperformed its Peers in the Pharmaceuticals Industry (QCOR, TEVA, VRX, SLXP, FRX)

Print Share

Dec 28, 2012 (Fast Lane via COMTEX) -- Below are five companies in the Pharmaceuticals industry that underperformed yesterday on a relative basis. This analysis was compiled based on yesterday's trading activity as we search for stocks that have could possible underperform its peers going forward.

Questcor Pharmaceuticals (NASDAQ:QCOR) ranks first with a loss of 7.09%; Teva Pharmaceutical Industries (NASDAQ:TEVA) ranks second with a loss of 1.26%; and Valeant Pharmaceuticals International (NYSE:VRX) ranks third with a loss of 1.06%.

Salix Pharmaceuticals (NASDAQ:SLXP) follows with a loss of 1.05% and Forest Laboratories (NYSE:FRX) rounds out the bottom five with a loss of 0.91%.Questcor Pharmaceuticals, Inc. develops and commercializes novel central nervous system-focused therapeutics that address significant unmet medical needs. The Company's primary product is a natural source adrenocorticotropic hormone indicated for the treatment of acute exacerbations of multiple sclerosis, as well as a number of other conditions.


Financial News Network Online (FNNO) is a leading provider of digital financial news content for distribution on the web. You can count on FNNO to bring you the latest market news, earnings reports, analyst comments, economic data reports and more. Visit today.

Copyright, Comtex News Network, Inc. 2012

Free Stock Analysis From Zacks

Includes Zacks Long-Term Recommendation and Target Price

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.